📣 VC round data is live. Check it out!
- Public Comps
- Generation Bio
Generation Bio Valuation Multiples
Discover revenue and EBITDA valuation multiples for Generation Bio and similar public comparables like Veru, Sprint Bioscience, Pluri, FibroGen and more.
Generation Bio Overview
About Generation Bio
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Founded
2016
HQ

Employees
115
Website
Financials (FY)
Market Cap
$36M
Valuation Multiples
Start free trialGeneration Bio Stock Performance
Generation Bio has current market cap of $36M.
Generation Bio's stock price is $5.34.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $36M | 0.0% | — | — | — | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGeneration Bio Valuation Multiples
Generation Bio Financial Valuation Multiples
As of May 5, 2026, Generation Bio has market cap of $36M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Generation Bio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Generation Bio Competitors
Generation Bio competitors include Veru, Sprint Bioscience, Pluri, FibroGen, Grace Therapeutics, Jiangsu Wuzhong Pharmaceutical, Boundless Bio, BioXcel Therapeutics, Mendus and Radiopharm Theranostics.
Most Generation Bio public comparables operate across Biopharmaceuticals, BioTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | (0.1x) | — | |||
| 1.2x | 1.4x | 2.0x | 2.7x | |||
| 43.8x | — | (2.7x) | — | |||
| — | 14.5x | — | (1.7x) | |||
| — | 28.2x | (0.8x) | (1.4x) | |||
| — | — | — | — | |||
| — | — | 0.4x | 0.4x | |||
| 180.1x | 117.3x | (2.2x) | (2.3x) | |||
This data is available for Pro users. Sign up to see all Generation Bio competitors and their valuation data. Start Free Trial | ||||||
Generation Bio Funding History
Before going public, Generation Bio raised $235M in total equity funding, across 3 rounds.
Generation Bio Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Generation Bio
| When was Generation Bio founded? | Generation Bio was founded in 2016. |
| Where is Generation Bio headquartered? | Generation Bio is headquartered in United States. |
| How many employees does Generation Bio have? | As of today, Generation Bio has over 115 employees. |
| Is Generation Bio publicly listed? | Yes, Generation Bio is a public company listed on Nasdaq. |
| What is the stock symbol of Generation Bio? | Generation Bio trades under GBIO ticker. |
| When did Generation Bio go public? | Generation Bio went public in 2020. |
| Who are competitors of Generation Bio? | Generation Bio main competitors include Veru, Sprint Bioscience, Pluri, FibroGen, Grace Therapeutics, Jiangsu Wuzhong Pharmaceutical, Boundless Bio, BioXcel Therapeutics, Mendus, Radiopharm Theranostics. |
| What is the current market cap of Generation Bio? | Generation Bio's current market cap is $36M. |
| Is Generation Bio profitable? | No, Generation Bio is not profitable. |
| How many companies Generation Bio has acquired to date? | Generation Bio hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Generation Bio has invested to date? | Generation Bio hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Generation Bio
Lists including Generation Bio
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.